Lataa...
Hyperprogression after immunotherapy
INTRODUCTION: Checkpoint inhibitors demonstrate very good anticancer effects, and some patients are long-time responders. As our experience to use these drugs increases, we see more and more patients having different kind of side effects which are usually not seen with chemotherapy. We have observed...
Tallennettuna:
| Julkaisussa: | South Asian J Cancer |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer - Medknow
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6852633/ https://ncbi.nlm.nih.gov/pubmed/31807489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_389_18 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|